357 related articles for article (PubMed ID: 37091144)
1. Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia.
Oder B; Chatzidimitriou A; Langerak AW; Rosenquist R; Österholm C
Front Oncol; 2023; 13():1143811. PubMed ID: 37091144
[TBL] [Abstract][Full Text] [Related]
2. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
Kulis M; Martin-Subero JI
Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.
Rodríguez-Vicente AE; Bikos V; Hernández-Sánchez M; Malcikova J; Hernández-Rivas JM; Pospisilova S
Oncotarget; 2017 Sep; 8(41):71234-71248. PubMed ID: 29050359
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Ouillette P; Saiya-Cork K; Seymour E; Li C; Shedden K; Malek SN
Clin Cancer Res; 2013 Jun; 19(11):2893-904. PubMed ID: 23620403
[TBL] [Abstract][Full Text] [Related]
5. Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH.
Lysenkova Wiklander M; Övernäs E; Lagensjö J; Raine A; Petri A; Wiman AC; Ramsell J; Marincevic-Zuniga Y; Gezelius H; Martin T; Bunikis I; Ekberg S; Erlandsson R; Larsson P; Mosbech MB; Häggqvist S; Hellstedt Kerje S; Feuk L; Ameur A; Liljedahl U; Nordlund J
BMC Res Notes; 2023 Oct; 16(1):265. PubMed ID: 37817248
[TBL] [Abstract][Full Text] [Related]
6. Genetic evolution in chronic lymphocytic leukaemia.
Delgado J; Villamor N; López-Guillermo A; Campo E
Best Pract Res Clin Haematol; 2016 Mar; 29(1):67-78. PubMed ID: 27742073
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants.
Hynst J; Plevova K; Radova L; Bystry V; Pal K; Pospisilova S
PeerJ; 2019; 7():e7071. PubMed ID: 31223530
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
[TBL] [Abstract][Full Text] [Related]
9. The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia.
Nagler A; Wu CJ
Blood; 2023 Jan; 141(4):369-379. PubMed ID: 36095842
[TBL] [Abstract][Full Text] [Related]
10. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
11. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
Condoluci A; Rossi D
J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
[TBL] [Abstract][Full Text] [Related]
12. Single-cell sequencing technology applied to epigenetics for the study of tumor heterogeneity.
Hu Y; Shen F; Yang X; Han T; Long Z; Wen J; Huang J; Shen J; Guo Q
Clin Epigenetics; 2023 Oct; 15(1):161. PubMed ID: 37821906
[TBL] [Abstract][Full Text] [Related]
13. Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.
Vardi A; Vlachonikola E; Karypidou M; Stalika E; Bikos V; Gemenetzi K; Maramis C; Siorenta A; Anagnostopoulos A; Pospisilova S; Maglaveras N; Chouvarda I; Stamatopoulos K; Hadzidimitriou A
Leukemia; 2017 Jul; 31(7):1555-1561. PubMed ID: 27904140
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
15. Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective.
Kwok M; Wu CJ
Front Oncol; 2021; 11():790004. PubMed ID: 34976831
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution.
Vardi A; Agathangelidis A; Sutton LA; Ghia P; Rosenquist R; Stamatopoulos K
Cancer Res; 2014 Aug; 74(16):4211-6. PubMed ID: 25074616
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.
Gaiti F; Chaligne R; Gu H; Brand RM; Kothen-Hill S; Schulman RC; Grigorev K; Risso D; Kim KT; Pastore A; Huang KY; Alonso A; Sheridan C; Omans ND; Biederstedt E; Clement K; Wang L; Felsenfeld JA; Bhavsar EB; Aryee MJ; Allan JN; Furman R; Gnirke A; Wu CJ; Meissner A; Landau DA
Nature; 2019 May; 569(7757):576-580. PubMed ID: 31092926
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
19. The Importance of an In-depth Study of Immunoglobulin Gene Rearrangements When Ascertaining the Clonal Relationship between Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma.
Trudel S; Ghamlouch H; Dremaux J; Delette C; Harrivel V; Marolleau JP; Gubler B
Front Immunol; 2016; 7():625. PubMed ID: 28082975
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
